FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897547895> ?p ?o ?g. }

• W2897547895 abstract "The origins of adverse reproductive outcome can be multifactorial, but the contribution of the maternal immune system is considered debatable. Elevated intracellular cytokine ratios have been proposed, although not universally supported, as a marker for immunological dysfunction in implantation and early pregnancy. Poor patient selection or inadequate treatment or testing may be confounding factors. Specific immunomodulation, in carefully selected sub-populations of ART patients with poor reproductive history, despite transfer of good quality blastocysts, may potentially improve clinical outcomes.Intracellular cytokine ratios (CKR) were prospectively assessed in 337 patients presenting with a history of implantation failure and/or pregnancy loss, prior to further treatment, and were found to be elevated in 150 (44.5%). Of this group, 134 agreed to initiate a standardised immunotherapy regime (nutraceuticals, prednisolone & intralipids) to evaluate the efficacy of this proposed therapy. Of the intervention population, a small cohort (n = 70) delayed commencing ART for ~ 10 weeks to assess if extended pre-treatment nutraceutical supplementation could normalise CKRs prior to starting ART, and if this conferred additional benefit.Baseline assessment in the intervention population (n = 134) identified 160 miscarriages from 180 total pregnancies (89% miscarriage rate, MR), conceived both spontaneously and by assisted reproduction. Post-treatment analysis of subsequent ART cycles revealed a significant improvement in both implantation (OR 3.0, 2.0-4.5) and miscarriage rates (41/97, 42.2% MR, P < 0.001). Interestingly, pre-treatment normalisation of CKRs appeared to impart marginal extra benefit prior to subsequent fertility treatment with immunotherapy.Following immunomodulation, significant improvements in both implantation rate and miscarriage rate were seen in this poor prognosis population. This suggests a possible role for both detailed immuno-evaluation of patients with poor reproductive history with good embryo quality, and application of personalised immunotherapy regimes alongside ART in selected cases. Future randomised controlled trials are needed to definitively evaluate this potentially promising therapeutic approach." @default.
• W2897547895 created "2018-10-26" @default.
• W2897547895 creator A5004377248 @default.
• W2897547895 creator A5078003536 @default.
• W2897547895 creator A5079667055 @default.
• W2897547895 creator A5085234016 @default.
• W2897547895 date "2018-10-17" @default.
• W2897547895 modified "2023-10-16" @default.
• W2897547895 title "ART implantation failure and miscarriage in patients with elevated intracellular cytokine ratios: response to immune support therapy" @default.
• W2897547895 cites W150505151 @default.
• W2897547895 cites W1572618653 @default.
• W2897547895 cites W1902194990 @default.
• W2897547895 cites W1945384627 @default.
• W2897547895 cites W1960545517 @default.
• W2897547895 cites W1963833538 @default.
• W2897547895 cites W1968123204 @default.
• W2897547895 cites W1983478056 @default.
• W2897547895 cites W1988427772 @default.
• W2897547895 cites W1998424689 @default.
• W2897547895 cites W2003324584 @default.
• W2897547895 cites W2005218310 @default.
• W2897547895 cites W2015813286 @default.
• W2897547895 cites W2028230033 @default.
• W2897547895 cites W2044478671 @default.
• W2897547895 cites W2047140527 @default.
• W2897547895 cites W2049790882 @default.
• W2897547895 cites W2052733000 @default.
• W2897547895 cites W2053696952 @default.
• W2897547895 cites W2055669282 @default.
• W2897547895 cites W2061461698 @default.
• W2897547895 cites W2063390572 @default.
• W2897547895 cites W2088981409 @default.
• W2897547895 cites W2094719443 @default.
• W2897547895 cites W2100592302 @default.
• W2897547895 cites W2101541068 @default.
• W2897547895 cites W2127770041 @default.
• W2897547895 cites W2127787195 @default.
• W2897547895 cites W2131284669 @default.
• W2897547895 cites W2132362451 @default.
• W2897547895 cites W2138665312 @default.
• W2897547895 cites W2144351209 @default.
• W2897547895 cites W2148246556 @default.
• W2897547895 cites W2158455292 @default.
• W2897547895 cites W2159849249 @default.
• W2897547895 cites W2165583740 @default.
• W2897547895 cites W2166089505 @default.
• W2897547895 cites W2166733275 @default.
• W2897547895 cites W2189513341 @default.
• W2897547895 cites W2223972615 @default.
• W2897547895 cites W2255265887 @default.
• W2897547895 cites W2256323204 @default.
• W2897547895 cites W2549251031 @default.
• W2897547895 cites W2612020810 @default.
• W2897547895 cites W2795509459 @default.
• W2897547895 cites W35382065 @default.
• W2897547895 cites W4253353642 @default.
• W2897547895 cites W49611453 @default.
• W2897547895 doi "https://doi.org/10.1186/s40738-018-0052-6" @default.
• W2897547895 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6192160" @default.
• W2897547895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30349731" @default.
• W2897547895 hasPublicationYear "2018" @default.
• W2897547895 type Work @default.
• W2897547895 sameAs 2897547895 @default.
• W2897547895 citedByCount "8" @default.
• W2897547895 countsByYear W28975478952019 @default.
• W2897547895 countsByYear W28975478952020 @default.
• W2897547895 countsByYear W28975478952021 @default.
• W2897547895 countsByYear W28975478952022 @default.
• W2897547895 countsByYear W28975478952023 @default.
• W2897547895 crossrefType "journal-article" @default.
• W2897547895 hasAuthorship W2897547895A5004377248 @default.
• W2897547895 hasAuthorship W2897547895A5078003536 @default.
• W2897547895 hasAuthorship W2897547895A5079667055 @default.
• W2897547895 hasAuthorship W2897547895A5085234016 @default.
• W2897547895 hasBestOaLocation W28975478951 @default.
• W2897547895 hasConcept C126322002 @default.
• W2897547895 hasConcept C203014093 @default.
• W2897547895 hasConcept C2776659692 @default.
• W2897547895 hasConcept C2777688143 @default.
• W2897547895 hasConcept C2779234561 @default.
• W2897547895 hasConcept C2779245376 @default.
• W2897547895 hasConcept C2780625311 @default.
• W2897547895 hasConcept C2908647359 @default.
• W2897547895 hasConcept C29456083 @default.
• W2897547895 hasConcept C2994278967 @default.
• W2897547895 hasConcept C3020098204 @default.
• W2897547895 hasConcept C500014431 @default.
• W2897547895 hasConcept C54355233 @default.
• W2897547895 hasConcept C71924100 @default.
• W2897547895 hasConcept C86803240 @default.
• W2897547895 hasConcept C99454951 @default.
• W2897547895 hasConceptScore W2897547895C126322002 @default.
• W2897547895 hasConceptScore W2897547895C203014093 @default.
• W2897547895 hasConceptScore W2897547895C2776659692 @default.
• W2897547895 hasConceptScore W2897547895C2777688143 @default.
• W2897547895 hasConceptScore W2897547895C2779234561 @default.
• W2897547895 hasConceptScore W2897547895C2779245376 @default.
• W2897547895 hasConceptScore W2897547895C2780625311 @default.
• W2897547895 hasConceptScore W2897547895C2908647359 @default.
• W2897547895 hasConceptScore W2897547895C29456083 @default.

• next